Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.
OBJECTIVE: Though effective anti-human immunodeficiency virus (HIV) therapies are now available, they have variable penetration into the brain. We therefore aimed to assess changes over calendar time in the risk for HIV-associated dementia (HIV-D), and factors associated with HIV-D risk. METHODS: Us...
Main Authors: | Bhaskaran, K, Mussini, C, Antinori, A, Walker, A, Dorrucci, M, Sabin, C, Phillips, A, Porter, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2008
|
Títulos similares
-
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
por: Marin, B, et al.
Publicado: (2009) -
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
por: Wolbers, M, et al.
Publicado: (2010) -
Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
por: Sridharan Sudharshan, et al.
Publicado: (2020-01-01) -
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.
por: Doerholt, K, et al.
Publicado: (2006) -
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
por: Bhaskaran, K, et al.
Publicado: (2004)